Zobrazeno 1 - 10
of 126
pro vyhledávání: '"L.V.A.M Beex"'
Publikováno v:
European Journal of Cancer. 35:386-391
The quality of adjuvant chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) and the compliance with guidelines for this treatment were studied in 323 premenopausal patients with node positive breast cancer, who were treated in t
Publikováno v:
European Journal of Cancer. 34:1677-1682
This paper outlines the changes which have occurred over the last 25 years in the methods employed for the measurement of oestrogen receptors to aid the management of women with breast cancer. Immunohistochemistry is now the method of choice and know
Publikováno v:
Journal of inherited metabolic disease, 21(3), 280-284. Springer Netherlands
Autor:
H.M.A. Brink, L.V.A.M. Beex
Publikováno v:
Documenta Ophthalmologica, 90, 1-6
Documenta Ophthalmologica, 90, 1, pp. 1-6
Documenta Ophthalmologica, 90, 1, pp. 1-6
Ocular side effects of systemic fluorouracil include excessive lacrimation, due to punctal and canalicular stenosis and fibrosis. Obstruction of the tear ducts after systemic therapy with fluorouracil is more frequent than is assumed. Five patients w
Autor:
L.V.A.M. Beex, R.T. Netea-Maier
Publikováno v:
Het oncologie formularium ISBN: 9789031362639
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4dbf4075705fb3eb18bcb7a27370213b
https://doi.org/10.1007/978-90-313-8682-6_8
https://doi.org/10.1007/978-90-313-8682-6_8
Autor:
L.V.A.M. Beex
Publikováno v:
Vademecum permanente nascholing huisartsen ISBN: 9789031388073
Vrouwelijke geslachtshormonen spelen een rol bij het ontstaan en de groei van mammacarcinoom. In tegenstelling tot vroegere gegevens blijken ook progestativa, evenals oestrogenen, in fysiologische doseringen tot proliferatie van mamma(tumor)weefsel t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfe78da7defe8aae2326a54bdc5cde2b
https://doi.org/10.1007/978-90-313-8808-0_673
https://doi.org/10.1007/978-90-313-8808-0_673
Autor:
L.V.A.M. Beex
Publikováno v:
Vademecum permanente nascholing huisartsen ISBN: 9789031388073
Oestrogenen en progesteron in doseringen zoals toegepast bij hormonale substitutiebehandeling bij postmenopauzale vrouwen, zijn stimulerende hormonen voor de borstklier en voor hormoonafhankelijk mammacarcinoom. Adjuvante en palliatieve endocriene be
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fa95a59c3c4f466ce47af5e9322d22d9
https://doi.org/10.1007/978-90-313-8808-0_583
https://doi.org/10.1007/978-90-313-8808-0_583
Autor:
A.B.P. van Kuilenburg, A. H. van Gennip, R. Meinsma, G.H. van Lenthe, R.A. de Abreu, L.V.A.M. Beex, P. Vreken
Publikováno v:
Advances in Experimental Medicine and Biology ISBN: 9781461374565
Dihydropyrimidine dehydrogenase (DPD) is responsible for the breakdown of the widely used antineoplastic agent 5-fluorouracil (5-FU), thereby limiting the efficacy of the therapy. It has been suggested that patients suffering from 5-FU toxicities due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e65c5a1a9657241d89ce9852fa5f1ca
https://doi.org/10.1007/978-1-4615-5381-6_58
https://doi.org/10.1007/978-1-4615-5381-6_58
Autor:
Chris M.G. Thomas, L.F.A.G. Massuger, Lambertus A. Kiemeney, A.L.M. Verbeek, C.P.T. Schijf, N.P. Koper, L.V.A.M. Beex
Publikováno v:
International Journal of Gynecological Cancer, 7, 127-133
European Journal of Gynaecological Oncology, 18, 271-271
International Journal of Gynecological Cancer, 7, pp. 127-133
European Journal of Gynaecological Oncology, 18, 2, pp. 271-271
European Journal of Gynaecological Oncology, 18, 271-271
International Journal of Gynecological Cancer, 7, pp. 127-133
European Journal of Gynaecological Oncology, 18, 2, pp. 271-271
Serum CA125 concentrations measured before and during chemotherapy may provide additional information for prognostic assessment of patients with epithelial ovarian cancer (EOC), and enable discrimination between patients who are likely to benefit fro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03209f5f2ae5fdeda226c9815555285f
http://hdl.handle.net/2066/24716
http://hdl.handle.net/2066/24716
Autor:
R.A. de Abreu, A.B.P. van Kuilenburg, L.V.A.M. Beex, P. Vreken, G.H. van Lenthe, A. H. van Gennip, R. Meinsma
Publikováno v:
European Journal of Cancer, 33, 2258-2264. Elsevier
Advances in Experimental Medicine and Biology, 431, 293-298
European Journal of Cancer, 33, 13, pp. 2258-2264
Advances in experimental medicine and biology, 431, 293-298. Springer New York
European Journal of Cancer, 33, 2258-2264
European journal of cancer (Oxford, England, 33(13), 2258-2264. Elsevier Limited
Advances in Experimental Medicine and Biology, 431, pp. 293-298
Advances in Experimental Medicine and Biology, 431, 293-298
European Journal of Cancer, 33, 13, pp. 2258-2264
Advances in experimental medicine and biology, 431, 293-298. Springer New York
European Journal of Cancer, 33, 2258-2264
European journal of cancer (Oxford, England, 33(13), 2258-2264. Elsevier Limited
Advances in Experimental Medicine and Biology, 431, pp. 293-298
Dihydropyrimidine dehydrogenase (DPD) is responsible for the breakdown of the widely used antineoplastic agent 5-fluorouracil (5-FU), thereby limiting the efficacy of the therapy. It has been suggested that patients suffering from 5-FU toxicities due
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e540d84076cf3b1bf936272defcc960c
https://dare.uva.nl/personal/pure/en/publications/heterozygosity-for-a-point-mutation-in-an-invariant-splice-donor-site-of-dihydropyrimidine-dehydrogenase-and-severe-5fluorouracil-related-toxicity(563c2607-cf97-47ee-917d-7dde6492548d).html
https://dare.uva.nl/personal/pure/en/publications/heterozygosity-for-a-point-mutation-in-an-invariant-splice-donor-site-of-dihydropyrimidine-dehydrogenase-and-severe-5fluorouracil-related-toxicity(563c2607-cf97-47ee-917d-7dde6492548d).html